Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1103920090150030370
Korean Journal of Hepatology
2009 Volume.15 No. 3 p.370 ~ p.374
A case of sudden-onset hearing loss in a patient treated with peginterferon ¥á-2b and ribavirin for chronic hepatitis C
Shin Min-Ki

Kim Tae-Hyo
Ju Kang
Ha Chang-Yoon
Min Hyun-Ju
Jung Woon-Tae
Lee Ok-Jae
Abstract
Combination therapy of pegylated interferon ¥á and ribavirin has been associated with various adverse effects, but sudden-onset hearing loss is uncommon. We report a 60-year-old male patient who developed sudden-onset hearing loss during combination therapy with pegylated interferon ¥á and ribavirin for chronic hepatitis C. This patient had been diagnosed with chronic hepatitis C (genotype Ib) and early-stage liver cirrhosis 3 years previously, and had been treated with conventional interferon-¥á and ribavirin for 12 months. However, 6 months from the end of the treatment course the patient relapsed and received combination retreatment with pegylated interferon ¥á-2b and ribavirin. He developed sudden-onset right-side hearing loss and tinnitus 42 weeks after the start of this retreatment. Pure-tone audiometry revealed a right-side hearing loss of 60~90dB. The patient consequently immediately discontinued the pegylated interferon therapy and was given prednisone 60 mg/day for 10 days, after which the hearing loss had almost completely recovered.
KEYWORD
Chronic hepatitis C, Peginterferon alfa-2b, Hearing loss, Sudden, Adverse effects
FullTexts / Linksout information
  
Listed journal information
MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø